Teva Must Pay Baxter's $144M Hepatitis Damages: Judge
By Bibeka Shrestha ( September 20, 2011, 5:45 PM EDT) -- A Delaware judge on Thursday upheld an arbitration panel's ruling that an indemnity agreement obligates Teva Pharmaceuticals USA Inc. to pay Baxter Healthcare Corp.'s damages — at least $144 million — in sweeping litigation blaming the drugmakers' marketing of anesthetic Propofol for a hepatitis C outbreak....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.